DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cefepime (Cefepime) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cefepime and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (116)
Death (15)
Life Threatening Events (20)
Disability (2)

Reports by Reaction Type

Renal Failure Acute (24)Confusional State (21)Encephalopathy (19)Myoclonus (17)Neurotoxicity (14)Status Epilepticus (12)Renal Failure (11)Diarrhoea (11)Pyrexia (9)Febrile Neutropenia (9)Altered State of Consciousness (9)Rhabdomyolysis (8)

Below are a few examples of reports where side effects / adverse reactions may be related to Cefepime. For a complete list or a specific selection of reports, please use the links above.

Possible Cefepime side effects in 84 year old male

Reported by a physician from United States on 2012-08-24

Patient: 84 year old male

Reactions: Drug Hypersensitivity, Condition Aggravated, Rash Morbilliform

Drug(s) suspected as cause:
Cefepime

Ceftriaxone

Other drugs received by patient: Piperacillin / Tazobactam; Esomeprazole Sodium; Meropenem



Possible Cefepime side effects in 17 year old male

Reported by a physician from Poland on 2012-08-23

Patient: 17 year old male

Reactions: Rhabdomyolysis, Disseminated Intravascular Coagulation, Pancytopenia, Pyrexia, Renal Failure, Neutropenia, Clostridial Infection, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Cefepime

Doxorubicin Hydrochloride
    Indication: Ewing's Sarcoma

Etoposide
    Indication: Ewing's Sarcoma Metastatic

Ifosfamide
    Indication: Ewing's Sarcoma Metastatic

Meropenem

Metronidazole

Netromycin

Vancocin Hydrochloride

Vincristine
    Indication: Ewing's Sarcoma Metastatic

Other drugs received by patient: Fluconazole; Caspofungin Acetate



Possible Cefepime side effects in 17 year old male

Reported by a consumer/non-health professional from United States on 2012-08-23

Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)

Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime
    Indication: Acute Myeloid Leukaemia

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-28

Cytarabine
    Dosage: unk
    Start date: 2012-05-18
    End date: 2012-05-18

Daunorubicin HCL
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-26



Possible Cefepime side effects in 57 year old female

Reported by a pharmacist from United States on 2012-08-22

Patient: 57 year old female, weighing 108.0 kg (237.6 pounds)

Reactions: Multi-Organ Failure, Drug Resistance, Status Epilepticus, Renal Failure Acute

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cefepime



Possible Cefepime side effects in 75 year old male

Reported by a health professional (non-physician/pharmacist) from Switzerland on 2012-08-20

Patient: 75 year old male, weighing 88.0 kg (193.6 pounds)

Reactions: Myoclonus, Drug Level Increased, Renal Failure Acute

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cefepime
    Indication: Intervertebral Discitis
    Start date: 2012-04-07
    End date: 2012-04-21

Citalopram Hydrobromide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-03

Duragesic-100
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-11
    End date: 2012-04-19

Lasilactone
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-07

Lasix
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-09
    End date: 2012-04-16

Lasix
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-04-07

Morphine
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-13

Torsemide
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-17

Tramadol Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-03-13
    End date: 2012-03-14

Vancocin Hydrochloride
    Indication: Intervertebral Discitis
    Start date: 2012-04-07
    End date: 2012-04-21

Other drugs received by patient: Metoprolol Tartrate; Moviprep; Dalteparin Sodium; Dalteparin Sodium; Novalgin; Folvite; Marcumar; Acetaminophen; Lyrica; Navoban; Cozaar; Imodium; Perenterol; Ondansetron; Dipiperon; Nitroderm; Motilium; Levothyroxine Sodium; Allopurinol; Konakion; Droperidol; Pantoprazole



Possible Cefepime side effects in 17 year old male

Reported by a consumer/non-health professional from Poland on 2012-08-09

Patient: 17 year old male

Reactions: Rhabdomyolysis, Pancytopenia, Clostridial Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Caspofungin Acetate

Cefepime

Doxorubicin Hydrochloride
    Indication: Ewing's Sarcoma Metastatic

Etoposide
    Indication: Ewing's Sarcoma Metastatic

Fluconazole

Ifosfamide
    Indication: Ewing's Sarcoma Metastatic

Metronidazole

Netromycin

Vincristine
    Indication: Ewing's Sarcoma Metastatic



Possible Cefepime side effects in 17 year old male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-08-02

Patient: 17 year old male

Reactions: Rhabdomyolysis, Pancytopenia, Clostridial Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Caspofungin Acetate

Cefepime

Doxorubicin Hydrochloride
    Indication: Ewing's Sarcoma Metastatic

Etoposide
    Indication: Ewing's Sarcoma Metastatic

Fluconazole

Ifosfamide
    Indication: Ewing's Sarcoma Metastatic

Metronidazole

Netromycin

Vincristine
    Indication: Ewing's Sarcoma Metastatic



Possible Cefepime side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-02

Patient:

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aspirin

Cefepime

Heparin Sodium

Meropenem

Nitro-DUR

Pepcid
    Administration route: Oral

Piperacillin and Tazobactam

Vancomycin

Zocor
    Administration route: Oral



Possible Cefepime side effects in 33 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient: 33 year old male, weighing 93.0 kg (204.6 pounds)

Reactions: Lactobacillus Infection, Blood PH Increased, Tachycardia, Blood PH Decreased, Device Related Infection, Scleral Haemorrhage, Bacterial Sepsis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Blood Bicarbonate Increased, Acute Respiratory Failure, Renal Failure Acute, Febrile Neutropenia, Haemodialysis, Alopecia, Treatment Failure, Base Excess Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
(Investigational Drug)
    Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-17
    End date: 2012-04-23

(Investigational Drug)
    Dosage: 60 mg, uid/qd, oral ; 60 mg, uid/qd, oral
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-02
    End date: 2012-04-08

Amphotericin B
    Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
    Indication: Fungal Infection
    Start date: 2012-05-06
    End date: 2012-05-08

Amphotericin B
    Dosage: 450 mg, uid/qd, intravenous (not otherwise specified)
    Indication: Infection Prophylaxis
    Start date: 2012-05-06
    End date: 2012-05-08

Aztreonam
    Dosage: see image
    Indication: Bacterial Infection
    Start date: 2012-05-06
    End date: 2012-05-07

Aztreonam
    Dosage: see image
    Indication: Bacterial Infection
    Start date: 2012-04-09
    End date: 2012-04-10

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-04-09

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-04-08
    End date: 2012-04-08

Caspofungin Acetate
    Dosage: see image
    Indication: Infection
    Start date: 2012-05-20
    End date: 2012-05-22

Cefepime
    Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-03-29
    End date: 2012-04-10

Cefepime
    Dosage: 2 g, q8 hours, intravenous (not otherwise specified) ; intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-06-02
    End date: 2012-06-05

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-14
    End date: 2012-04-20

Cytarabine
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-30
    End date: 2012-04-05

Daunorubicin HCL
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-03-30
    End date: 2012-04-01

Daunorubicin HCL
    Dosage: see image
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-04-14
    End date: 2012-04-16

Imipenem and Cilastatin
    Dosage: 1000 mg, q8 hours intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-05-07
    End date: 2012-05-28

Penicillin G
    Dosage: 24000000 u, q24 hrs intravenous (not otherwise specified)
    Indication: Infection
    Start date: 2012-05-04
    End date: 2012-05-09

Vancomycin
    Indication: Product Used FOR Unknown Indication

Voriconazole
    Dosage: 522 mg, q12 hours, intravenous (not otherwise specified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-05-08
    End date: 2012-05-08

Other drugs received by patient: Ondansetron; Seroquel; Percocet; Nystatin; Zyloprim; Acetaminophen; Calcium Carbonate; Lorazepam; Xanax; Allopurinol; Calcium Gluconate; Ibuprofen; Hydroxyzine Pamoate; Celexa



Possible Cefepime side effects in 65 year old female

Reported by a physician from India on 2012-07-30

Patient: 65 year old female

Reactions: Myoclonus, Chorea, Aphasia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime



Possible Cefepime side effects in 17 year old male

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-23

Patient: 17 year old male

Reactions: Abdominal Pain, Rhabdomyolysis, Pain in Extremity, Disseminated Intravascular Coagulation, Chromaturia, Pancytopenia, Pyrexia, Renal Failure, Renal Impairment, Diarrhoea, Clostridial Infection, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cefepime
    Indication: Pyrexia

Doxorubicin HCL
    Indication: Ewing's Sarcoma Metastatic

Etoposide
    Indication: Ewing's Sarcoma Metastatic

Ifosfamide
    Indication: Ewing's Sarcoma Metastatic

Netilmicin Sulfate
    Indication: Pyrexia

Vincristine
    Indication: Ewing's Sarcoma Metastatic



Possible Cefepime side effects in 61 year old female

Reported by a consumer/non-health professional from France on 2012-07-20

Patient: 61 year old female, weighing 120.0 kg (264.0 pounds)

Reactions: Confusional State, Overdose, Status Epilepticus

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cefepime

Other drugs received by patient: Tenormin; Esidrix



Possible Cefepime side effects in 67 year old female

Reported by a consumer/non-health professional from France on 2012-07-11

Patient: 67 year old female

Reactions: Overdose, Rectal Haemorrhage, Hypotension, Pancytopenia, Encephalopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cefepime
    Indication: Osteomyelitis
    Start date: 2012-06-02
    End date: 2012-06-06

Piperacillin
    Dosage: intead of 6gm/day ,2mg/day introduced
    Indication: Osteomyelitis
    Start date: 2012-06-04
    End date: 2012-06-07

Other drugs received by patient: Acupan; Levothyroxine Sodium; Folic Acid; Vancomycin; Rabeprazole Sodium; Omeprazole; Oxycodone HCL; Gentamicin



Possible Cefepime side effects in 61 year old female

Reported by a pharmacist from United States on 2012-07-11

Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Dysarthria, Tremor, Dysphemia

Drug(s) suspected as cause:
Cefepime

Other drugs received by patient: Senna-Mint WAF; Oxycodone HCL and Acetaminophen; Potassium Chloride; Oxybutynin; Praastatin; Prochlorperazine; Allergy Relief Capsule



Possible Cefepime side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-05

Patient: male, weighing 86.0 kg (189.2 pounds)

Reactions: Musculoskeletal Pain, Hyponatraemia, Pyrexia, Purpura, Hypokalaemia, Hypophosphataemia, Oedema Peripheral, Hypomagnesaemia, Deep Vein Thrombosis, Muscle Spasms

Drug(s) suspected as cause:
Ambisome
    Dosage: unk
    Indication: Fungal Infection
    Start date: 2012-04-28
    End date: 2012-04-30

Cefepime
    Dosage: unk
    Indication: Fungal Infection
    End date: 2012-05-03

Other drugs received by patient: Etoposide; Cytarabine; Idarubicin HCL



Possible Cefepime side effects in 14 year old female

Reported by a physician from United States on 2012-07-03

Patient: 14 year old female, weighing 60.4 kg (132.9 pounds)

Reactions: Stomatitis, Hypotension, Encephalopathy, Acidosis, Hypercalcaemia, Respiratory Failure, Sepsis, Posterior Reversible Encephalopathy Syndrome, Hypocalcaemia, Enterocolitis, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: unk
    Indication: Candida Test Positive
    Start date: 2012-05-20

Calcium Gluconate

Cefepime
    Dosage: unk
    Indication: Klebsiella Infection
    Start date: 2012-05-10

Dexamethasone Sodium Phosphate
    Dosage: 10 mg/m2, bid or iv on days 1-5 and 15-19
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Methotrexate Sodium
    Dosage: 8-15 mg (age based dosing) it on days 1 (or up to 72 hours prior to day 1) and 8
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Mitoxantrone Hydrochloride
    Dosage: 10 mg/m2, over 30 minutes on days 1 and 2
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Pegaspargase
    Dosage: 2500 iu/m2 over 1 hr on days 3 and 17
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Temsirolimus
    Dosage: 7.5 mg/m2, over 30 minutes on days i, 8 and 15 (max dose: 15 mg)
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Vincristine Sulfate
    Dosage: 1.5 mg/m2 cyclic (max 2 mg) over i-5 minutes or infusion via mini bag on days 1, 8, i5 and 22
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30



Possible Cefepime side effects in 67 year old female

Reported by a physician from France on 2012-06-29

Patient: 67 year old female

Reactions: Overdose, Hypotension, Rectal Haemorrhage, Pancytopenia, Encephalopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cefepime
    Indication: Osteomyelitis
    Start date: 2012-06-02
    End date: 2012-06-06

Piperacillin
    Indication: Osteomyelitis
    Start date: 2012-06-04
    End date: 2012-06-07

Other drugs received by patient: Acupan; Gentamicin; Omeprazole; Oxycodone HCL; Rabeprazole Sodium; Levothyroxine Sodium; Folic Acid; Vancomycin



Possible Cefepime side effects in 58 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 58 year old male, weighing 75.0 kg (165.0 pounds)

Reactions: Skin Lesion, Rash Maculo-Papular

Drug(s) suspected as cause:
Allopurinol
    Dosage: 300mg qd po
    Administration route: Oral
    Indication: Tumour Lysis Syndrome
    Start date: 2012-06-21
    End date: 2012-06-23

Allopurinol
    Dosage: 300mg qd po
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-06-21
    End date: 2012-06-23

Cefepime
    Dosage: 2g q8h iv
    Indication: Evidence Based Treatment
    Start date: 2012-06-21
    End date: 2012-06-22

Cefepime
    Dosage: 2g q8h iv
    Indication: Infection
    Start date: 2012-06-21
    End date: 2012-06-22



Possible Cefepime side effects in 14 year old female

Reported by a physician from United States on 2012-06-28

Patient: 14 year old female, weighing 60.4 kg (132.9 pounds)

Reactions: Stomatitis, Hypotension, Encephalopathy, Acidosis, Hypercalcaemia, Respiratory Failure, Sepsis, Posterior Reversible Encephalopathy Syndrome, Hypocalcaemia, Enterocolitis, Cardiac Arrest

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ambisome
    Dosage: unk
    Indication: Candida Test Positive
    Start date: 2012-05-20

Calcium Gluconate

Cefepime
    Dosage: unk
    Indication: Klebsiella Infection
    Start date: 2012-05-10

Dexamethasone Sodium Phosphate
    Dosage: 10 mg/m2, bid or iv on days 1-5 and 15-19
    Administration route: Oral
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Methotrexate
    Dosage: 8-15 mg (age based dosing) it on days 1 (or up to 72 hours prior to day 1) and 8
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Mitoxantrone Hydrochloride
    Dosage: 10 mg/m2, over 30 minutes on days 1 and 2
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Pegaspargase
    Dosage: 2500 iu/m2 over 1 hr on days 3 and 17
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Temsirolimus
    Dosage: 7.5 mg/m2, over 30 minutes on days i, 8 and 15 (max dose: 15 mg)
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30

Vincristine
    Dosage: 1.5 mg/m2 cyclic (max 2 mg) over i-5 minutes or infusion via mini bag on days 1, 8, i5 and 22
    Indication: B Precursor Type Acute Leukaemia
    Start date: 2012-04-30



Possible Cefepime side effects in 46 year old female

Reported by a pharmacist from United States on 2012-06-19

Patient: 46 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Vitamin K Deficiency, Drug Resistance, Inhibitory Drug Interaction

Drug(s) suspected as cause:
Cefepime
    Indication: Subcutaneous Abscess

Nafcillin
    Indication: Endocarditis Staphylococcal

Vancomycin
    Indication: Subcutaneous Abscess

Other drugs received by patient possibly interacting with the suspect drug:
Infuvite Pediatric
    Dosage: 150 microg daily
    Indication: Hypophagia

Intralipid / 00272201 /
    Dosage: 20% soya oil emulsion (250ml), 132.5 microg vitamin k on mon, wed, fri
    Indication: Hypophagia

Warfarin Sodium
    Dosage: 1mg daily
    Indication: Deep Vein Thrombosis

Other drugs received by patient: Heparin



Possible Cefepime side effects in 46 year old female

Reported by a pharmacist from United States on 2012-06-19

Patient: 46 year old female, weighing 75.0 kg (165.0 pounds)

Reactions: Vitamin K Deficiency, Drug Resistance, Inhibitory Drug Interaction

Drug(s) suspected as cause:
Cefepime
    Indication: Subcutaneous Abscess

Nafcillin
    Indication: Endocarditis Staphylococcal

Vancomycin
    Indication: Subcutaneous Abscess

Other drugs received by patient possibly interacting with the suspect drug:
Infuvite Pediatric
    Dosage: 150 microg daily
    Indication: Hypophagia

Intralipid / 00272201 /
    Dosage: 20% soya oil emulsion (250ml), 132.5 microg vitamin k on mon, wed, fri
    Indication: Hypophagia

Warfarin Sodium
    Dosage: 1mg daily
    Indication: Deep Vein Thrombosis

Other drugs received by patient: Heparin



Possible Cefepime side effects in 17 year old male

Reported by a physician from United States on 2012-06-15

Patient: 17 year old male, weighing 89.9 kg (197.8 pounds)

Reactions: Pharyngeal Inflammation, Hypoxia, Caecitis, Rash Maculo-Papular, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cytarabine
    Dosage: unk
    Start date: 2012-05-18
    End date: 2012-05-18

Cytarabine
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-28

Daunorubicin Hydrochloride
    Dosage: 50 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Etoposide
    Dosage: 100 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-22

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Acute Myeloid Leukaemia
    Start date: 2012-05-18
    End date: 2012-05-26



Possible Cefepime side effects in 84 year old

Reported by a health professional (non-physician/pharmacist) from France on 2012-06-14

Patient: 84 year old

Reactions: Neurotoxicity, Overdose, Clonus, Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime



Possible Cefepime side effects in 49 year old

Reported by a individual with unspecified qualification from France on 2012-06-14

Patient: 49 year old

Reactions: Neurotoxicity, Confusional State, Overdose, Creatinine Renal Clearance Decreased, Drug Level Increased, Somnolence

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime



Possible Cefepime side effects in

Reported by a pharmacist from United States on 2012-06-08

Patient:

Reactions: Thrombocytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aspirin
    Indication: Product Used FOR Unknown Indication

Cefepime
    Indication: Product Used FOR Unknown Indication

Famotidine
    Indication: Product Used FOR Unknown Indication

Famotidine

Heparin
    Indication: Product Used FOR Unknown Indication

Meropenem
    Indication: Product Used FOR Unknown Indication

Nitroglycerin
    Indication: Product Used FOR Unknown Indication

Piperacillin and Tazobactam
    Indication: Product Used FOR Unknown Indication

Simvastatin
    Indication: Product Used FOR Unknown Indication

Vancomycin
    Indication: Product Used FOR Unknown Indication



Possible Cefepime side effects in 91 year old male

Reported by a physician from United States on 2012-06-04

Patient: 91 year old male, weighing 83.9 kg (184.6 pounds)

Reactions: Delirium

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime



Possible Cefepime side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 59 year old male

Reactions: Tubulointerstitial Nephritis, Renal Failure, Encephalopathy, Drug Rash With Eosinophilia and Systemic Symptoms

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cefepime



Possible Cefepime side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-05-30

Patient: 47 year old female, weighing 68.0 kg (149.6 pounds)

Reactions: Hepatomegaly, Respiratory Disorder, Respiratory Tract Haemorrhage, Candidiasis, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Amphotericin B
    Dosage: 30 mg/day, 6 hours of infusion
    Indication: Candidiasis

Cefepime
    Dosage: 2 g, every eight hours
    Indication: Febrile Neutropenia

Cytarabine
    Dosage: 370 mg/m2/day
    Indication: Acute Promyelocytic Leukaemia

Fluconazole
    Dosage: 200 mg/day
    Administration route: Oral
    Indication: Candidiasis

Metamizole
    Dosage: 500 mg
    Administration route: Oral
    Indication: Febrile Neutropenia

Mitoxantrone
    Dosage: 20 mg/m2/day
    Indication: Acute Promyelocytic Leukaemia

Tretinoin
    Dosage: 40 mg/m2/day continuously
    Administration route: Oral
    Indication: Acute Promyelocytic Leukaemia

Other drugs received by patient: Meropenem; Methotrexate; Tretinoin



Possible Cefepime side effects in 45 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-23

Patient: 45 year old female, weighing 60.0 kg (132.0 pounds)

Reactions: Confusional State, Dyskinesia, Hypotonia, Altered State of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cefepime
    Dosage: 6 g, 1x/day
    Indication: Cord Blood Transplant Therapy
    Start date: 2011-12-30
    End date: 2012-01-15

Cyclophosphamide
    Dosage: 1905 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-06

Fludarabine Phosphate
    Dosage: 68 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-05
    End date: 2012-01-08

Neoral
    Dosage: unk
    Start date: 2011-10-29
    End date: 2012-01-15

Targocid
    Dosage: 400 mg, 1x/day
    Start date: 2011-12-27
    End date: 2012-01-15

Thymoglobulin
    Dosage: 476 mg, unk
    Indication: Cord Blood Transplant Therapy
    Start date: 2012-01-09
    End date: 2012-01-10

Vfend
    Dosage: 400 mg, 1x/day
    Indication: Candidiasis
    Start date: 2011-12-30
    End date: 2012-01-15



Possible Cefepime side effects in 53 year old male

Reported by a pharmacist from United States on 2012-05-22

Patient: 53 year old male

Reactions: Convulsion

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cefepime

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017